Association between type 1 and type 2 diabetes and risk of non-Hodgkin's lymphoma: A meta-analysis of cohort studies.

[1]  J. Tuomilehto,et al.  Cancer incidence among Finnish people with type 2 diabetes during 1989–2014 , 2018, European Journal of Epidemiology.

[2]  K. Hidayat,et al.  Anthropometric factors and non-Hodgkin's lymphoma risk: systematic review and meta-analysis of prospective studies. , 2018, Critical reviews in oncology/hematology.

[3]  S. Gibson,et al.  Metformin Is Not Associated with Incidence Risk of Non-Hodgkin Lymphomas among Diabetic Patients , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Randy D Gascoyne,et al.  Non-Hodgkin lymphoma , 2016, Medicine.

[5]  P. Boffetta,et al.  Time-Dependent Risk of Cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults. , 2016, American journal of epidemiology.

[6]  D. Serraino,et al.  Cancer among patients with type 2 diabetes mellitus: A population-based cohort study in northeastern Italy. , 2016, Cancer epidemiology.

[7]  X. Shu,et al.  Type 2 diabetes and the risk of non-Hodgkin’s lymphoma: a report from two population-based cohort studies in China , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  F. Hu,et al.  Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. , 2015, The lancet. Diabetes & endocrinology.

[9]  S. Sharp,et al.  Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis , 2015, Diabetes Care.

[10]  S. Bell,et al.  Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies , 2015, Diabetes Care.

[11]  F. Sloan,et al.  Relation between BMI and Diabetes Mellitus and Its Complications among US Older Adults , 2015, Southern medical journal.

[12]  N. Hou,et al.  Epidemiology and etiology of non-hodgkin lymphoma. , 2015, Cancer treatment and research.

[13]  J. Shaw,et al.  Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation , 2014, Diabetes Care.

[14]  Shiyue Li,et al.  Systematic Reviews and Meta- and Pooled Analyses Reduced Risk of Lung Cancer With Metformin Therapy in Diabetic Patients: A Systematic Review and Meta-Analysis , 2014 .

[15]  Q. Ma,et al.  Hyperglycemia, a Neglected Factor during Cancer Progression , 2014, BioMed research international.

[16]  Stephen S. Lim,et al.  Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys , 2014, BMJ : British Medical Journal.

[17]  G. Steil,et al.  Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes , 2013, Diabetes Care.

[18]  E. Petridou,et al.  Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease , 2013, European Journal of Cancer Prevention.

[19]  P. Hartge,et al.  The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study. , 2013, The Journal of clinical endocrinology and metabolism.

[20]  F. Sung,et al.  Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients , 2013, International journal of cancer.

[21]  C. la Vecchia,et al.  Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis. , 2012 .

[22]  J. Armitage,et al.  Non-Hodgkin lymphoma , 2012, The Lancet.

[23]  J. Mitri,et al.  Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. , 2012, Blood.

[24]  J. Castillo,et al.  Cigarette smoking is associated with a small increase in the incidence of non-Hodgkin lymphoma: a meta-analysis of 24 observational studies , 2012, Leukemia & lymphoma.

[25]  Zhi‐Jie Zheng,et al.  Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[26]  C. Tseng.  Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan. , 2012 .

[27]  H. Kan,et al.  Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes , 2011, Diabetes Care.

[28]  Jun Liu,et al.  Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. , 2011, European journal of cancer.

[29]  P. Allebeck,et al.  Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. , 2011, International journal of epidemiology.

[30]  K. McGlynn,et al.  Risk of cancer in a large cohort of U.S. veterans with diabetes , 2011, International journal of cancer.

[31]  M. Goldacre,et al.  Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies , 2011, Diabetologia.

[32]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[33]  K. Hemminki,et al.  Risk of Cancer Following Hospitalization for Type 2 Diabetes , 2010, The oncologist.

[34]  Wanqing Chen,et al.  [Study on cancer incidence through the cancer registry program in 11 cities and counties, China]. , 2009, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[35]  L. Kolonel,et al.  Common immune‐related risk factors and incident non‐Hodgkin lymphoma: The multiethnic cohort , 2009, International journal of cancer.

[36]  A. Morris,et al.  A cohort study of the risk of cancer associated with type 2 diabetes , 2009, British Journal of Cancer.

[37]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[38]  J. Mitri,et al.  Diabetes and Risk of Non-Hodgkin's Lymphoma , 2008, Diabetes Care.

[39]  C. Chao,et al.  Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. , 2008, American journal of epidemiology.

[40]  E. Riboli,et al.  Diabetes and the risk of non-Hodgkin’s lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition , 2008, Haematologica.

[41]  F. Frasca,et al.  The role of insulin receptors and IGF-I receptors in cancer and other diseases , 2008, Archives of physiology and biochemistry.

[42]  S. Larsson,et al.  Obesity and risk of non‐Hodgkin's lymphoma: A meta‐analysis , 2007, International journal of cancer.

[43]  W. Cozen,et al.  Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[44]  K. Kuriki,et al.  Diabetes and cancer risk for all and specific sites among Japanese men and women , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[45]  A. Tamakoshi,et al.  Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. , 2006, Asian Pacific journal of cancer prevention : APJCP.

[46]  D. Albanes,et al.  Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.

[47]  S. de Sanjosé,et al.  Type 2 diabetes mellitus, its treatment and risk for lymphoma. , 2005, European journal of cancer.

[48]  N. Waugh,et al.  Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study , 2005, British Journal of Cancer.

[49]  Paul J Nietert,et al.  Hypertension, diabetes, hypercholesterolemia, and their combinations increased health care utilization and decreased health status. , 2004, Journal of clinical epidemiology.

[50]  R. Mertelsmann,et al.  Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology , 2004, Annals of Hematology.

[51]  E. Giovannucci.  Nutrition, Insulin, Insulin-like Growth Factors and Cancer , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[52]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[53]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[54]  J. Cerhan,et al.  Medical history risk factors for non-Hodgkin's lymphoma in older women. , 1997, Journal of the National Cancer Institute.

[55]  A. Green,et al.  Cancer and diabetes ‐ a follow‐up study of two populationbased cohorts of diabetic patients , 1997, Journal of internal medicine.

[56]  H. Adami,et al.  Medical history risk factors for non-Hodgkin's lymphoma in older women. , 1997, Journal of the National Cancer Institute.

[57]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[58]  L. Melton,et al.  Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. , 1982, Journal of chronic diseases.